Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

504 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Evidence of Epidemiology and Clinical Outcomes in Multiple Myeloma, Findings from the Registry of Hemato-Oncologic Malignancies in Colombia, Observational Study.
Abello V, Mantilla WA, Idrobo H, Sossa CL, Salazar LA, Pena A, Herrera JM, Guerrero P, Espinosa D, Quintero-Vega GE, Munevar I, Galvez K, Henao A, Gómez R, Saavedra JD, Gaviria LM, Osuna M, Mateos MV. Abello V, et al. Among authors: mateos mv. Clin Lymphoma Myeloma Leuk. 2022 Jun;22(6):e405-e413. doi: 10.1016/j.clml.2021.12.009. Epub 2021 Dec 13. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35042679 Free article.
The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
López-Pérez R, García-Sanz R, González D, Balanzategui A, Chillón MC, Alaejos I, Mateos MV, Caballero MD, Mateo G, Nieto MJ, González M, San Miguel JF. López-Pérez R, et al. Among authors: mateos mv. Leukemia. 2000 Aug;14(8):1493-9. doi: 10.1038/sj.leu.2401862. Leukemia. 2000. PMID: 10942248 Clinical Trial.
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis.
Gutiérrez NC, Castellanos MV, Martín ML, Mateos MV, Hernández JM, Fernández M, Carrera D, Rosiñol L, Ribera JM, Ojanguren JM, Palomera L, Gardella S, Escoda L, Hernández-Boluda JC, Bello JL, de la Rubia J, Lahuerta JJ, San Miguel JF; GEM/PETHEMA Spanish Group. Gutiérrez NC, et al. Among authors: mateos mv. Leukemia. 2007 Jan;21(1):143-50. doi: 10.1038/sj.leu.2404413. Epub 2006 Oct 5. Leukemia. 2007. PMID: 17024116 Clinical Trial.
[Multiple myeloma].
García-Sanz R, Mateos MV, San Miguel JF. García-Sanz R, et al. Among authors: mateos mv. Med Clin (Barc). 2007 Jun 16;129(3):104-15. doi: 10.1157/13107365. Med Clin (Barc). 2007. PMID: 17594862 Review. Spanish.
Bortezomib in multiple myeloma.
Mateos MV, San Miguel JF. Mateos MV, et al. Best Pract Res Clin Haematol. 2007 Dec;20(4):701-15. doi: 10.1016/j.beha.2007.09.003. Best Pract Res Clin Haematol. 2007. PMID: 18070714 Review.
Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.
Lahuerta JJ, Mateos MV, Martínez-López J, Rosiñol L, Sureda A, de la Rubia J, García-Laraña J, Martínez-Martínez R, Hernández-García MT, Carrera D, Besalduch J, de Arriba F, Ribera JM, Escoda L, Hernández-Ruiz B, García-Frade J, Rivas-González C, Alegre A, Bladé J, San Miguel JF. Lahuerta JJ, et al. Among authors: mateos mv. J Clin Oncol. 2008 Dec 10;26(35):5775-82. doi: 10.1200/JCO.2008.17.9721. Epub 2008 Nov 10. J Clin Oncol. 2008. PMID: 19001321
Multiple myeloma: treatment evolution.
San Miguel JF, Mateos MV, Ocio E, Garcia-Sanz R. San Miguel JF, et al. Among authors: mateos mv. Hematology. 2012 Apr;17 Suppl 1:S3-6. doi: 10.1179/102453312X13336169154971. Hematology. 2012. PMID: 22507766
Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.
González-Calle V, Dávila J, Escalante F, de Coca AG, Aguilera C, López R, Bárez A, Alonso JM, Hernández R, Hernández JM, de la Fuente P, Puig N, Ocio EM, Gutiérrez NC, García-Sanz R, Mateos MV. González-Calle V, et al. Among authors: mateos mv. Leukemia. 2016 Oct;30(10):2026-2031. doi: 10.1038/leu.2016.123. Epub 2016 May 2. Leukemia. 2016. PMID: 27133826
504 results